ASPB-PIPB Combination in Cardiac Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSisli Hamidiye Etfal Training and Research Hospital

About this trial

Cardiopulmonary bypass surgery is associated with significant postoperative pain, which may adversely affect respiratory function, delay mobilization, prolong hospital stay, and increase postoperative complications. Within Enhanced Recovery After Surgery (ERAS) protocols, multimodal analgesia and opioid-sparing strategies have become essential components of perioperative care. Ultrasound-guided fascial plane blocks, including the anterior serratus plane block (ASPB) and pectoral-intercostal plane block (PIPB), have emerged as effective and safe regional anesthesia techniques for cardiac surgery, targeting different sensory innervation of the thoracic wall. However, evidence regarding the combined use of these two blocks remains limited. This study aimed to evaluate whether the combination of ASPB and PIPB improves intraoperative and postoperative analgesia, reduces opioid consumption, and enhances postoperative recovery and ERAS outcomes compared with standard analgesic management in patients undergoing cardiopulmonary bypass surgery.

Eligibility criteria

Qualifiers

Patients undergoing open heart surgery via median sternotomy by the Cardiovascular Surgery Clinic

Patients over 18 years of age

ASA II-III patients

Disqualifiers

- Patients undergoing emergency or recurrent surgery

Patients with left ventricular ejection fraction < 30

Patients who died per-operatively

Patients who do not provide informed consent

Trial design

Treatments tested in this trial

  • Combined ASPB and PIPB
  • Anterior Serratus Plane Block

Treatment groups

60 Participants
are divided into 2 treatment groups